Efavirenz CsA 509

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits when using this combination
Drug 1
Drug 2
Clinical Effects

decreased effects of immunosuppresant

Management

if co administiring, monitor immunosuppressant efficacy

Import ID
509